Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals

/PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV), a leading addiction treatment company, today announced that it has gained exclusive global rights to develop,...

Related Keywords

United States ,Hong Kong ,Macau ,China ,Taiwan ,Christian Heidbreder ,Alar Pharmaceuticals Inc ,Nasdaq ,Prnewswire Indivior ,Lead Asset ,First Three Month ,Dalar Pharmaceuticals ,Chief Scientific ,Indivior Plc ,